Live from the NIH registry
Studies recruiting near Indianapolis right now
Top 25 of 915 recruiting studies, sorted by proximity — each links to its official registry page
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
Innovative Hematology, Inc. (IHI) — Indianapolis, Indiana (0.9 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Large Cell Lymphoma, Diffuse, Relapsed Cancer
Phase 2
Interventional 35 participants sought
Indiana University Melvin and Bren Simon Comprehensive Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: Dipenkumar Modi
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Riley Hospital for Children — Indianapolis, Indiana (0.9 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Community Health Network, Inc — Indianapolis, Indiana (0.9 mi)
· Sponsor: Relay Therapeutics, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Indiana University Health Riley Hospital for Children — Indianapolis, Indiana (0.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Josephson Wallack Munshower Neurology, P.C. — Indianapolis, Indiana (0.9 mi)
· Sponsor: Annovis Bio Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Indiana University/Melvin and Bren Simon Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: SWOG Cancer Research Network
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Indiana University/Melvin and Bren Simon Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: NRG Oncology
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Solid Tumor, Adult, Metastatic Breast Cancer
Phase 1
Interventional 392 participants sought
Indiana University Simon Comprehensive Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Indiana University Melvin and Bren Simon Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
Indiana University Health — Indianapolis, Indiana (0.9 mi)
· Sponsor: C4 Therapeutics, Inc.
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis
Neurotrophic Keratitis
Phase 2
Interventional 54 participants sought
Midwest Cornea Associates — Carmel, Indiana (14.0 mi)
· Sponsor: TearSolutions, Inc.
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Indiana University School of Medicine — Indianapolis, Indiana (0.9 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Indiana University Health — Carmel, Indiana (14.0 mi)
· Sponsor: University of Alabama at Birmingham
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up
Asthma, Pulmonary Function
N/A
Observational 225 participants sought
Indiana University — Indianapolis, Indiana (0.9 mi)
· Sponsor: Oregon Health and Science University
rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression
Depression, Treatment Resistant
N/A
Interventional 20 participants sought
Goodman Hall Neuroscience Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Indianapolis, Indiana (0.9 mi)
· Sponsor: Sameek Roychowdhury
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Parkinson Disease
Phase 2
Interventional 150 participants sought
Josephson Wallack Munshower Neurology PC (Site #231) — Indianapolis, Indiana (0.9 mi)
· Sponsor: Appello Pharmaceuticals, Inc.
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Primary Mitochondrial Disease
Phase 2
Interventional 180 participants sought
IU Health University Hospital — Indianapolis, Indiana (0.9 mi)
· Sponsor: Pharming Technologies B.V.
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Noblesville, Indiana (19.9 mi)
· Sponsor: AstraZeneca
Post-Operative Thoracolumosacral Orthosis for PJK
Proximal Junctional Kyphosis, Adult Spinal Deformity Surgery
Phase 4
Interventional 84 participants sought
Indiana Spine Group — Carmel, Indiana (14.0 mi)
· Sponsor: Hospital for Special Surgery, New York
Clinical Course Of Disease In Participants With FA-CM
Friedreich Ataxia, Cardiomyopathy
N/A
Observational 65 participants sought
Indiana University - Riley Children's Health — Indianapolis, Indiana (0.9 mi)
· Sponsor: Lexeo Therapeutics
Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Methicillin Resistant Staphylococcus Aureus, Osteomyelitis Acute
Phase 4
Interventional 100 participants sought
Riley Hospital for Children — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria
Phenylketonuria
Phase 1
Interventional 20 participants sought
Indiana University — Indianapolis, Indiana (0.9 mi)
· Sponsor: Agios Pharmaceuticals, Inc.
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction
Phase 3
Interventional 2,000 participants sought
St. Vincent Medical Group — Indianapolis, Indiana (0.9 mi)
· Sponsor: Uppsala University